175 related articles for article (PubMed ID: 27064393)
1. A Targeted Inhibitor of the Alternative Complement Pathway Accelerates Recovery From Smoke-Induced Ocular Injury.
Woodell A; Jones BW; Williamson T; Schnabolk G; Tomlinson S; Atkinson C; Rohrer B
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1728-37. PubMed ID: 27064393
[TBL] [Abstract][Full Text] [Related]
2. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Wilson RB; Huang Y; Qiao F; Tang PH; Kunchithapautham K; Gilkeson GS; Tomlinson S
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3056-64. PubMed ID: 19264882
[TBL] [Abstract][Full Text] [Related]
3. Subretinal Rather Than Intravitreal Adeno-Associated Virus-Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage.
Annamalai B; Parsons N; Nicholson C; Obert E; Jones B; Rohrer B
Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):11. PubMed ID: 33830174
[TBL] [Abstract][Full Text] [Related]
4. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration.
Annamalai B; Parsons N; Nicholson C; Joseph K; Coughlin B; Yang X; Jones BW; Tomlinson S; Rohrer B
Exp Eye Res; 2021 Jun; 207():108583. PubMed ID: 33878326
[TBL] [Abstract][Full Text] [Related]
5. Smoke exposure causes endoplasmic reticulum stress and lipid accumulation in retinal pigment epithelium through oxidative stress and complement activation.
Kunchithapautham K; Atkinson C; Rohrer B
J Biol Chem; 2014 May; 289(21):14534-46. PubMed ID: 24711457
[TBL] [Abstract][Full Text] [Related]
6. Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury.
Woodell A; Coughlin B; Kunchithapautham K; Casey S; Williamson T; Ferrell WD; Atkinson C; Jones BW; Rohrer B
PLoS One; 2013; 8(6):e67894. PubMed ID: 23825688
[TBL] [Abstract][Full Text] [Related]
7. Immunization Against Oxidized Elastin Exacerbates Structural and Functional Damage in Mouse Model of Smoke-Induced Ocular Injury.
Annamalai B; Nicholson C; Parsons N; Stephenson S; Atkinson C; Jones B; Rohrer B
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):45. PubMed ID: 32207814
[TBL] [Abstract][Full Text] [Related]
8. Peptide-based immunotherapy against oxidized elastin ameliorates pathology in mouse model of smoke-induced ocular injury.
Rohrer B; Parsons N; Annamalai B; Nicholson C; Obert E; Jones BW; Dick AD
Exp Eye Res; 2021 Nov; 212():108755. PubMed ID: 34487725
[TBL] [Abstract][Full Text] [Related]
9. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model.
Parsons NB; Annamalai B; Rohrer B
Transl Vis Sci Technol; 2023 Jul; 12(7):17. PubMed ID: 37462980
[TBL] [Abstract][Full Text] [Related]
10. Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.
Schnabolk G; Coughlin B; Joseph K; Kunchithapautham K; Bandyopadhyay M; O'Quinn EC; Nowling T; Rohrer B
Invest Ophthalmol Vis Sci; 2015 Jan; 56(3):1850-63. PubMed ID: 25593023
[TBL] [Abstract][Full Text] [Related]
11. Lack of paraoxonase 1 alters phospholipid composition, but not morphology and function of the mouse retina.
Oczos J; Sutter I; Kloeckener-Gruissem B; Berger W; Riwanto M; Rentsch K; Hornemann T; von Eckardstein A; Grimm C
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4714-27. PubMed ID: 25028362
[TBL] [Abstract][Full Text] [Related]
12. AMD-like retinopathy associated with intravenous iron.
Song D; Kanu LN; Li Y; Kelly KL; Bhuyan RK; Aleman T; Morgan JI; Dunaief JL
Exp Eye Res; 2016 Oct; 151():122-33. PubMed ID: 27565570
[TBL] [Abstract][Full Text] [Related]
13. Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
Rohrer B; Coughlin B; Bandyopadhyay M; Holers VM
J Ocul Pharmacol Ther; 2012 Aug; 28(4):402-9. PubMed ID: 22309197
[TBL] [Abstract][Full Text] [Related]
14. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD.
Espinosa-Heidmann DG; Suner IJ; Catanuto P; Hernandez EP; Marin-Castano ME; Cousins SW
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):729-37. PubMed ID: 16431974
[TBL] [Abstract][Full Text] [Related]
15. Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina.
Cashman SM; Desai A; Ramo K; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3436-45. PubMed ID: 21357400
[TBL] [Abstract][Full Text] [Related]
16. A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.
Rohrer B; Long Q; Coughlin B; Renner B; Huang Y; Kunchithapautham K; Ferreira VP; Pangburn MK; Gilkeson GS; Thurman JM; Tomlinson S; Holers VM
Adv Exp Med Biol; 2010; 703():137-49. PubMed ID: 20711712
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment with a 5HT1a agonist induces anti-oxidant protection and preserves the retina from mitochondrial oxidative stress.
Biswal MR; Ahmed CM; Ildefonso CJ; Han P; Li H; Jivanji H; Mao H; Lewin AS
Exp Eye Res; 2015 Nov; 140():94-105. PubMed ID: 26315784
[TBL] [Abstract][Full Text] [Related]
18. Repurposing an orally available drug for the treatment of geographic atrophy.
Ahmed CM; Biswal MR; Li H; Han P; Ildefonso CJ; Lewin AS
Mol Vis; 2016; 22():294-310. PubMed ID: 27110092
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Extracellular Matrix/Bruch's Membrane Can Cause the Activation of the Alternative Complement Pathway via Tick-Over.
Fernandez-Godino R
Adv Exp Med Biol; 2018; 1074():29-35. PubMed ID: 29721924
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated delivery of CD46 attenuates the alternative complement pathway on RPE: implications for age-related macular degeneration.
Sweigard JH; Cashman SM; Kumar-Singh R
Gene Ther; 2011 Jun; 18(6):613-21. PubMed ID: 21307887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
